Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

(2018) Bryan Williams et al.   Lancet Diabetes & Endocrinology

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Intensive Blood Pressure Treatment for Resistant Hypertension

(2018) Tetsuro Tsujimoto et al.   HYPERTENSION

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Heart failure with preserved ejection fraction in hypertension

(2016) Loon Yee Louis Teo et al.   CURRENT OPINION IN CARDIOLOGY

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease

(2014) Paul Muntner et al.   HYPERTENSION

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Resistant Hypertension

(2012) Eduardo Pimenta et al.   CIRCULATION

Baseline Characteristics of Patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

(2012) Sanjiv J. Shah et al.   Circulation-Heart Failure

Aerobic Exercise Reduces Blood Pressure in Resistant Hypertension

(2012) Fernando Dimeo et al.   HYPERTENSION

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

(2011) Akshay S. Desai et al.   AMERICAN HEART JOURNAL